Last reviewed · How we verify

NCT05223127

Aloe Vera on Caesarean Section Wound

Not yet recruiting NA Last updated 14 November 2023
What this trial tests

NA trial testing Aloe vera in Cesarean Section in 60 participants. Not yet recruiting.

Timeline
1 August 2024
Primary endpoint
1 September 2025
30 October 2026

Quick facts

Lead sponsorKTO Karatay University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment60
Start date1 August 2024
Primary completion1 September 2025
Estimated completion30 October 2026

Drugs / interventions tested

Conditions studied

Sponsor

KTO Karatay University

Who can join

Adults 18 to 35, female only, with Cesarean Section. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Conducting clinical research in line with the literature recommendation, with a method that is low-cost, accessible, easy-to-use, and examined in an evidence-based design related to cesarean section wound, which negatively affects the quality of life of women in the postpartum period, constitutes the original value and our main motivation of the project.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Aloe vera

Trials testing the same drug.

Other recruiting trials for Cesarean Section

Currently open trials in the same condition.

Other KTO Karatay University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05223127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing